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ABSTRACT
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ADVISOR: Robert J. Lauzon, PhD.
Apoptosis is a highly organized intracellular death program in multicellular
animals. In the vertebrate immune system, apoptosis plays a central role in preventing the
emergence of autoreactive lymphocytes. In this study, we used multiple stimuli
(staurosporine, camptothecin, and cytokine deprivation - interleukin-2 or IL-2) to initiate
apoptosis in IL-2 dependent, mouse HT-2 T-lymphocytes. All three inducers triggered
DNA laddering and phosphatidylserine externalization. Propidium iodide staining and
flow cytometry were also used to determine whether apoptotic cells accumulated in a
specific stage of the cell cycle, and whether the mode of induction affected cell cycle
distribution. Our findings indicate that IL-2 deprivation induces HT-2 cells to accumulate
in G1, while cells treated with staurosporine and camptothecin accumulated in G2/M and
S phase, respectively. We also used immunopblotting detection to investigate P27Kip1
protein expression for each condition. P27Kip1 is a member of the Cip/Kip family of
cyclin-dependent kinase inhibitors whose function is to enforce the G1 restriction point.
We found that P27Kip1 levels were significantly increased within 12 hrs and 6 hrs
following both IL-2 deprivation and campthotecin exposure, respectively. Across all time
points in the staurosporine experiments, P27Kip1 steady state levels were decreased. These
results suggest that the mode by which apoptosis is induced differentially affects cell
cycle distribution.
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Introduction
Apoptosis is a highly regulated biological process in which specific
morphological and biochemical processes trigger controlled cell destruction. It is a vital
contributory process to multicellular organismal development and homeostasis (Vaux,
1993). This active process is necessary for closely monitoring the disposal and recycling
of contents in aged, diseased, and dying cells. Apoptosis can be characterized by three
distinct phases: initiation, commitment, and execution. Initiation is marked by
physiological, biological, chemical, and physical stimuli that activate the death pathway,
such as phosphatidylserine externalization. The cell then undergoes physical changes,
such as permeabilization of the mitochondrial outer membrane, that irreversibly commit
it to death (Keeble & Gilmore, 2007). The commencement of execution is marked by
phenotypic changes in the cell, including cell shrinkage, chromatin condensation, and
compression of organelles without loss of ultrastructure, in the dense cytoplasm (Kerr et
al., 1972). This final execution ends as the cell blebs, or pinches its contents off in small
vesicles called apoptotic bodies that can be digested by neighboring or circulating
phagocytes (Walsh, 2014). Highly organized and specific, this mechanism for cellular
suicide removes cells with minimal accidental damage to the host organism.
Cells also undergo other, more harmful forms of cell death, the most common
being necrosis. While apoptosis targets cellular destruction in individual or specific
clusters of cells, necrosis distinctly affects large areas of cells (Jain et al., 2014). In
contrast with apoptosis, necrotic cell death is associated with cellular swelling, loss of
membrane integrity, and a severe, host inflammatory response, as necrotic cells release
their contents into the surrounding tissue (Elmore, 2007). This degradative process was
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once thought to be passive and energy-independent, but recent studies suggest that it may
be more regulated than initially thought (Bell et al., 2008; Ch’en et al., 2008; Bell &
Walsh, 2009). Similarly to apoptosis, the process is preceded by mitochondrial
permeability transition: this is a genetically driven process where pores in the
mitochondrial outer membrane open, disrupting salt and proton gradients and irreversibly
inhibiting the organelle’s function (Kroemer, 2014). Both cell death pathways can occur
simultaneously, and they require close monitoring to maintain health and viability in
multicellular organisms. Specifically, apoptotic deregulation can lead to terminal
conditions, such as cancers, autoimmune diseases, metabolic disorders, neurogenerative
diseases, and stroke (Hanahan & Weinberg, 2000; Prasad & Prabhakar, 2003; McKenzie
et al., 2004; Rohn et al., 2001; Prunell et al., 2005). It is therefore important to
understand this mechanism for programmed cell death, as it holds a vast array of
applications in the scientific and medical fields.
Because apoptosis essentially avoids tissue inflammation, it plays an essential role
in the resolution of the immune response at the organismal level (Kurosaka et al., 2003).
More than simply a non-inflammatory reaction, apoptosis has been linked to promoting
immunosuppressive effects of phagocytes during cell clearance (Savill & Fadok, 2000;
Albert et al. 1998). The activity of phagocytes that bind and ingest apoptotic cells is a
critical homeostatic mechanism that controls effector lymphocyte populations (Savill et
al., 2002). Regulation of these effector immune cells have shown that apoptosis inhibits
inflammation by simultaneously increasing secretion of anti-inflammatory and
immunoregulatory cytokines and decreasing secretion of the pro-inflammatory cytokines
(Voll et al. 1997). Lymphocytes are fast replicating, non-cancerous, and karotypically
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normal cells that can regulate immune response through apoptosis. Because of their
indispensable role multicellular organismal immunity, these cells are the focus of our
research. The current study sought to evaluate apoptosis induction in cultured HT-2
mouse T-lymphocytes by investigating the effectiveness of various known apoptosis
triggering agents.
Stimulation of apoptosis in mammalian cells can occur both intra- and
extracellularly. The intrinsic pathway propagates via non-receptor mediated intracellular
signals, specifically through mitochondrial release of pro-apoptotic members of the Bcl-2
protein family into the cytoplasm (Schleich & Lavrik, 2013). This pathway is often
selected when a cell’s DNA content is damaged or has been exposed to toxins or
radiation. The extrinsic pathway requires extrinsic ligands to bind trans-membrane death
receptors on the cell’s membrane surface. These signaling molecules transduce the death
signal to intracellular caspases that initiate the apoptotic response. Surface expression of
the death receptors can vary significantly between cell types. Specifically, these receptors
are often down-regulated or absent in drug-resistant cancer cell lines (Fulda, 2006). In
this study, we used three known apoptosis inducers to examine both pathways.
Interleukin (IL)-2 deprivation, camptothecin, and staurosporine treatments were
used to initiate the apoptotic response. IL-2 is a cytokine that binds cell surface receptors
that transduce this signal via protein kinases, which in turn, are responsible for T-cell
growth and survival. It is the quintessential growth factor involved in the production of
T-lymphocytes (Huleatt et al., 2003). Cells incubated with this growth factor enter the
cell cycle and divide. Without this growth and regulatory signaling molecule, the cell
ceases to proliferate and an extrinsic apoptotic response is initiated (Tsai et al., 2013).
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Camptothecin also sets off an extrinsic, death-receptor pathway, and does so by inhibiting
DNA topoisomerase I (Jacobs et al., 2007). When DNA is replicated, the strands can
become tightly coiled. DNA topoisomerase I functions to alleviate supercoiled DNA by
clipping one of the strands, unwinding it, and rejoining the ends. Camptothecin
deactivates the enzyme by binding an intermediate involved in DNA unwinding,
subsequently increasing DNA cleavage without repair (Hertzberg, 1989). Initially
isolated from the bark of a Chinese tree, Camptotheca acuminata, camptothecin was used
in clinical testing in the 1970s for cancer treatment (Pommier, 2006). The drug was
suspended due to associated side effects, but subsequent derivatives have continued to
treat a variety of cancers, causing these cells to shrink and die (Kyle et al., 2014; Zeng et
al. 2014). The final inducer used was staurosporine, an initiator of intrinsic-pathway
apoptosis through kinase c inhibition (Li et al., 2009). It is known be nearly universal in
its ability to induce apoptosis in nucleated cells (Bertrand et al., 1994). Staurosporine
typically induces the mitochondrion-dependent pathway of apoptosis; however, provided
the cell is able activate specific caspases, the pathway divides again between caspasedependent and independent mechanisms (Castro et al., 2010; Belmokhtar et al., 2001).
Given their known mechanisms for induction, the three treatments were used to disrupt
normal cell division at various stages of the cell cycle. We hypothesized that IL-2
deprivation would target the G1 phase, camptothecin, S phase, and staurosporine, G2/M
phase.
The initial intention of the study was to determine if the three known inducing
agents also provoke changes in cell cycle distribution using flow cytometry. We also
sought to correlate any of these observed changes in distribution prior to cell death with
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early markers for apoptosis using annexin V staining to detect and quantify
phosphatidylserine externalization via flow cytometry. We finally wished to characterize
expression of critical regulatory proteins of the cell cycle. We hoped to connect their
regulation and steady state levels with the time points that marked distribution changes
and early apoptotic changes.
P27Kip1 is a G1/S phase cyclin-dependent kinase (cdk) inhibitor that stops cells at
the G1/S phase boundary (Levkau et al., 1998). Movement of cells from G1 into S phase
is regulated specifically by cdk2, a cyclin-dependent kinase enzyme that forms a complex
with cyclin A and E, and facilitates progression through the cell cycle. Cell cycle arrest
at the G1/S phase boundary by P27Kip1 has been found to cause apoptosis in both
cancerous and non-cancerous cell lines, including mesangial cells, fibroblasts, endothelial
cells, small cell lung cancers, erythroleukemia cells, and T-lymphocytes (Hiromura et al.,
1999; Lavkau et al., 1998; Masuda et al., 2001; Drexler & Pebler, 2003; Huleatt et al.,
2003). While the significance of this G1/S phase check point and importance of P27Kip1
is agreed upon in the field, debate over how exactly P27Kip1 regulates apoptotic pathways
continues.
Excess levels of the protein have been found to both promote and discourage
entrance of cells into apoptosis. Some studies suggest that P27Kip1 inhibitor can serve to
protect cells from apoptosis by constraining cdk2 activity (Hiromura et al., 1999). In the
absence of specific growth factors, CDK2 activity leads to apoptosis. Further studies
attribute cell enhanced survival rate to proteasome inhibitor protection caused by the
expression of p27Kip1 (Drexler & Pebler, 2003). Other investigators have found that
upregulation of p27Kip1 levels protect cells from apoptosis in unfavorable
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microenvironments, such as hypoxic or low nutrient conditions (Masuda et al., 2001). In
contrast, other studies have uncovered that cell proliferation and differentiation require
low levels of P27Kip1 (Hiromura et al., 1999). Steady state levels of the cdk inhibitor may
not be the sole determining factor of cellular demise, but rather work in conjunction with
environmental or molecular factors. In contrast to the upregulation of p27Kip1 in cells that
were grown in low nutrient conditions, cells grown in complete medium had very few
apoptotic cells (Masuda et al., 2001). While high levels of p27Kip1 may delay the cell
from transitioning to S-phase, reducing its concentration will not guarantee proliferation
if cdk2 activity is compromised and all necessary growth factors are not present
(Bruggeman et al., 2010). It is clear that P27Kip1 plays an essential role in monitoring the
fate of cells as they progress through the cell cycle, however the inhibitor’s interplay with
surrounding growth factors, environmental conditions, and enzyme interaction is not yet
fully understood.
It is important to recognize that p27Kip1‘s role in proliferation is not dichotomous
with its participation in apoptosis. In some instances, its upreguation has been found to
retard proliferation, but not necessarily induce apoptosis (Drexler & Pebler, 2003). This
characteristic is important when developing cancer treatments or connecting protein
steady state levels to gene expression. Therapy for non-small cell lung cancers has been
specialized to target p27Kip1 to inhibit growth by reducing viability (Eymin & Brambilla,
2004). Other cancers respond better with reintroduced p27Kip1 that induces apoptosis.
More than simply regulating this protein’s steady state levels, it is important to recognize
the critical role that gene expression, post-translational modification, and intracellular
localization play in the inhibitory function of p27Kip1 in the cell. Ishii et al. (2004) studied
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P27Kip1 in human lung adenocarcinoma, and found that the extent of phosphorylation
effected localization of the inhibitory protein in the cell. More complete phosphorylation
status lead to greater localization to the cytoplasm, where the protein is functional. This
specific localization pattern was associated with the cytoprotective function of P27Kip1.
Cytoplasmic localization of P27Kip1 has also been associated with an anti- apoptotic
function in breast cancer cells, leading to poor prognosis in these afflicted patients (Lian
et al., 2002). Elucidating the many pathways involved in P27Kip1 function and regulation
may provide the answer to cell survival and fate.
The aim of this study was to further examine the role of three inducers
(interleukin-2 deprivation, camptothecin and staurosporine) in initiating apoptosis and
how each affected cell cycle distribution in IL-2 dependent, mouse HT-2, T-lymphocytes
via flow cytometry. We hypothesized that interleukin-2 deprived cells would accumulate
in G1 prior to initiating DNA fragmentation, whereas camptothecin and staurosporine
exposure would induce S and G2/M phase arrest, respectively. The timeframe required
for complete cellular fragmentation was also determined with each apoptosis inducer.
Our findings indicate that apoptosis in IL-2 deprived and camptothecin treated cells
correlated temporally with an early increase in P27Kip1 steady state levels, and decreased
expression following staurosporine treatment. Collectively, these results suggest an
important interplay between the inducer’s role and the cell’s response to life or death in
cultured mouse T-lymphocytes.
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Methods
Culturing from frozen stock
HT-2 cell stocks were thawed quickly from storage in a -80oC liquid nitrogen
container and rested for 10 minutes at room temperature. These cells were then
transferred into a sterile 15mL centrifuge tube. 10mL of growth medium made with
Dulbecco’s Modified Eagle’s Medium (containing 5 mM D-glucose), 5 x 10-5 M betamercaptoethanol, 2m M L-glutamine, 50 µg/mL gentamycin, 10 mM Hepes buffer pH =
7.2, 10% interleukin-2 (Roche, Indianapolis, IN), and 10% fetal bovine serum (Atlanta
Biologicals, Flowery Branch, GA) was added slowly to the cells over 5 minutes. The
cell/media mixture was then centrifuged at 8000rpms, 12oC for 8 minutes, decanted, and
resuspended in 10 mL of growth media. The cells were transferred to a culture flask
(Sigma-Adlrich, St. Louis, MS) and incubated at 5% CO2 at 37oC.

Cell line maintenance
The cells were maintained at the indicated cell concentrations shown in Table 1.
Table 1. Cell concentration maintenance.
Media Volume (mL)

10

20

30

40

Maximum Number of Cells (million cells)

4

8

12

16

Cells were passaged every 4-5 days and seeded at a density of 104 cells/mL.
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Determining optimal cell concentration for DNA extraction from IL-2 deprived cells
HT-2 cells were grown to a density of 8 million in a final volume of 20 mL IL-2
(+) medium, transferred to two 15 mL tubes, and centrifuged at 1200 rpms, 12oC for 8
minutes. The cells were washed twice in 10 mL IL-2 (–) media and seeded into four, 10
mL flasks. Two flasks containing 10 mL IL-2 (+) media served as controls and grown to
a density of 200,000 and 100,000 cells/mL, respectively. Since the cells would undergo
two cell cycles in 24hr incubation period (each cell cycle was previously determined to
be approximately 12 hours), one control flask was seeded with 250,000 and the other
with 500,000 cells to obtain the target concentrations. The remaining two flasks
contained 10 mL of IL-2 (–) media, and the cells were grown to the same density. Their
volumes were selected assuming that these cells would finish their current cycle before
arresting, and so one was seeded with 500,000 cells, and the other, 1,000,000 cells. Cells
were grown in a humidified incubator at 37oC and 5% carbon dioxide.

Empirical determination of optimal cell and inducer concentrations for genomic DNA
isolation from camptothecin-treated cells
Preparation for the campthothecin experiment was similar to IL-2 deprivation,
however HT-2 cells were not washed, but instead, maintained in IL-2 (+) media. Cells
were incubated at 24hrs and grown to 200,000 cells/mL in all flasks. IL2 controls were
prepared as described above, but experimental flasks were seeded at their final cell
concentration, 200,000 cells/mL, assuming immediate arrest following toxin exposure. 30
and 60 µL volumes (6 and 12 µM respectively) of a camptothecin stock previously
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dissolved in dimethysulfoxide (DMSO) and DMSO alone were added to each of the two
experimental flasks and control flasks, respectively.

Determining optimal cell concentration for genomic DNA isolation from staurosporinetreated cells
Preparation for the staurosporine experiment was identical to camptothecin,
except for the following: a) concentration was varied between 100,000 and 200,000
cells/mL b) 5 µL (1µM) stock staurosporine was added to each experimental c) 5 µL
DMSO was added to each control d) cells were incubated for 12 hrs. Low concentrations
of staurosporine had previously been observed by us and others to induce cell cycle arrest
(Zong, 1999, Lauzon, unpublished observations). Because of its high potency to induce
apoptosis at 1µM concentration, the incubation period for this experiment was shortened
and concentration fixed to determine optimal cell concentration.

Genomic DNA isolation
Genomic DNA was isolated according to the manufacturer’s specifications
(Roche). Briefly, cells were transferred from their flasks to 15 mL tubes and centrifuged
at 8000 rpm, 12oC for 8 minutes. They were then washed in phosphate buffered saline
(PBS) pH=7.4 and transferred into microfuge tubes. The cells were spun at 3000 rpms for
1 min and the cell pellet resuspended with 200 µL of PBS and 200 µL of lysis buffer. The
solution was incubated at 72oC for 10 minutes. After incubation, 100 µL isopropanol was
added, and the lysate was transferred to a filter tube. The contents were spun through the
filter tube at 8000 rpms for 1 minute and the flow-through, discarded. The cells were
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washed twice in 500 µL wash buffer and spun at 8000 rpms/1min. An additional spin was
carried out at 13,000 rpms for 30 seconds to remove any excess wash buffer. The filter
tube was finally transferred to a clean microfuge tube and genomic DNA was eluted with
40 µL of pre-warmed elution buffer.

Agarose gel electrophoresis
Genomic DNA was size-fractionated via agarose gel electrophoresis in 50 mM
Tris Acetate EDTA (TAE) buffer solution (pH = 8.0) for 60 minutes at 70 volts. DNA
samples were prepared using 8 µL of isolated DNA and 2 µL EZ-vision loading dye
(Amresco, Solon, OH) and electrophoresed in 2% agarose gels. Digital images were
obtained using a G box gel documentation system (Syngene, Frederick, MD).

Cell cycle analysis
Given the results obtained from gel electrophoresis testing, cells were grown to
200,000 cells/mL concentrations in 10 mL flasks for all inducer experiments. Time
course experiments were developed based on previous experiments, literature, and
inducer behavior. IL-2 deprived cells were harvested at 12, 24, and 36 hours, and
camptothecin and staurosporine at 3, 6, 12, and 24 hours. These cells were prepared for
flow cytometry cell cycle analysis according to the Guava® Cell Cycle Reagent protocol
(EMD Millipore, Billerica, MA).
Prior to adding the reagent, the cells were fixed in 70% ethanol. At their
respective time points, incubated cells were spun at 450 x g for 5 minutes in 50 mL
centrifuge tubes. Once the supernatant was removed, 25 mL of 1x PBS was added to the
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tube. The cells were spun under the same conditions, and the supernatant was again
removed leaving approximately 500µL in the tube. Cells were resuspended and added
dropwise to a 50 mL tube containing 30 mL of ice-cold 70% ethanol while vortexing at
medium speed. They were stored at 4oC until flow cytometry analysis.
The alcohol-fixed cells were isolated by centrifugation and washed in 1 mL PBS.
They were then transferred to a 15 mL centrifuge tube and the cell concentration was
adjusted to 200,000 cells/sample. They were spun at 450 x g for 5 minutes, and the PBS
supernatant was removed. 200 µL of Guava Cycle Reagent (EMD Millipore) was added
to the cells. The samples were incubated for 30 minutes at room temperature in the dark
prior to acquiring the data on a guava Flow Cytometry easyCyte System (EMD
Millipore).

Lysate preparation
5 million HT-2 cells were incubated with 400 µl of hot lysis buffer (125 mM TrisHCl, pH = 6.8, 2%SDS, 5% glycerol, 0.003% bromophenol blue, 1% β-mercaptethanol
previously heated for three minutes at 100°C). Genomic DNA was sheared using a 26gauge needle and syringe, and lysates were aliquoted and stored at -70°C until needed for
protein quantification and sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE).

Protein quantification
HT-2 T lymphocyte lysates were diluted 1/25 in ultrapure water. Protein standards
were prepared using Bovine Serum Albumin (Thermo Scientific, Waltham, MA) in a
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series of concentrations of 0 0.1, 0.2, 0.4, and 0.6 mg/mL in 4% lysis buffer previously
mixed with ultrapure water. 50 µL of each lysate or BSA protein standard was mixed
with 1.5 mL of Coomassie Plus Protein Assay Reagent (Thermo Scientific) and added to
plastic cuvettes. Absorbances were determined using a Genesys 20 spectrophotometer
(Thermo Spectronic, Waltham, MA) at 595 nm. Unknown concentrations were
determined using regression analysis in Microsoft Excel.

SDS-PAGE and western blotting
20 µg of HT-2 cell lysates were used for SDS-PAGE. The lysates and 10 µl of
Kaleidoscope pre-stained molecular weight standards (Bio-Rad, Hercules, CA) were
boiled for three minutes at 95°C in a block heater. Samples were briefly centrifuged,
placed on ice and subsequently loaded into a 4-15% Tris-HCl precast, gradient gel (BioRad) placed in a mini-protean II electrophoresis apparatus (Bio-Rad). Duplicate sets of
each sample were size-fractionated in 1x running buffer (5 mM Tris, 192 mM glycine,
0.1% SDS) along with 10 µl of Kaleidoscope protein standards at 120V for
approximately 50 minutes or until the tracking dye reached the bottom of the gel.
The gel and a piece of Optitran Nitrocellulose membrane (Schleicher & Schuell,
Keene, NH) pre-cut to the gel’s dimensions were soaked for 20 minutes in transfer buffer
(50 mM Tris Base, 384 mM glycine, 20% methanol, 0.01% SDS). Four pieces of
Whatman filter gel blot paper (Schleicher & Schuell) cut to the same dimensions as the
membrane and gel were also soaked for 20 minutes in transfer buffer, and the gel was
placed atop two pieces of filter paper. The nitrocellulose paper was placed over the gel,
and the remaining pieces of filter paper were placed on top of the membrane. The gel-

13

nitrocellulose sandwich was placed face down on a WD Trans-Blot apparatus (Bio-Rad)
and blotted for 20 minutes at 15 volts. The nitrocellulose membrane was removed,
allowed to dry and cut to size.

Immunostaining and analysis
The two membranes were placed in separate Nalgene wash containers (Thermo
Scientific) for 60 minutes on a bench top circular shaker containing 10 mL of blocking
buffer (5% non-fat dry milk, 10 mM Tris-HCl ph=7.5, 100 mM NaCl, 0.1% Tween 20).
Blocking buffer was removed and replaced with primary antibodies in 10 mL of blocking
buffer. The membrane was incubated with either a mouse monoclonal anti-alpha tubulin
antibody (Sigma-Aldrich) or a rabbit polyclonal anti Kip 1 (p27) antibody (Cell Signaling
Technology, Danvers, MA) at dilutions of 1:10,000 and 1:1000, respectively.
Incubations with the primary antibody were carried out overnight at 4oC on an orbital
shaker at low speed. The nitrocellulose membrane was washed four times, ten-minutes
each in wash buffer (10 mM Tris pH=7.5, 100 mM NaCl, 0.1% Tween 20). Tubulin
samples were subsequently incubated with a secondary, alkaline phosphatase conjugated
goat anti-mouse IgG antibody (Jackson Immunoresearch, Bar Harbor, ME), while Kip 1
(p27) samples were incubated with secondary, alkaline phosphatase conjugated goat antirabbit IgG antibody (Jackson Immunoresearch). Both secondary antibodies were diluted
1:1000 in blocking buffer. Incubations were carried out at room temperature on a
circular shaker for 2 hours. The membranes were washed four times for ten minutes each
with wash buffer and briefly rinsed in 10 mM tris/HCl buffer pH = 7.2 or ultrapure water
to remove excess Tween 20 detergent. They were subsequently incubated in the dark with
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200 µl of nitro blue tetrazolium/ bromo chloro indolyl phosphate (NBT/BCIP) substrate
(Roche Diagnostics, Indianapolis, IN) in 10 mL of alkaline phosphatase buffer (100 mM
NaCl, 5 mM MgCl2, 100 mM Tris, pH=9.5) on a shaker, until color developed.

Annexin staining for early apoptosis
HT-2 cells were grown to a concentration of 200,000 cells/mL, and harvested at
12 and 24 hours for IL-2 deprivation and 3, 6, 12, and 24 hours for camptothecin and
staurosporine experiments, respectively. The cells were subsequently prepared for flow
cytometry analysis using the Guava® Nexin Reagent protocol (EMD Millipore). Cells
were spun and resuspended in PBS with 1% fetal bovine serum (FBS) (Atlanta
Biologicals). Their concentration was maintained at 200,000 cells/mL and 100µL was
added to an equal volume Guava Nexin Reagent (EMD Millipore). Samples were
incubated for 20 minutes at room temperature in the dark prior to acquiring the data on a
guava Flow Cytometry easyCyte System (EMD Millipore).
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Results
Optimizing cell and inducer concentrations through DNA fragmentation analysis
Initial testing of IL-2 deprivation, camptothecin, and staurosporine treatments
identified the ideal cell and inducer concentrations required to standardize subsequent
experiments. Using agarose gel electrophoresis data, internucleosomal DNA
fragmentation (DNA laddering) was observed in IL-2 deprived cells at both cell
concentrations, 100,000 and 200,000 cells/mL (Fig. 1a). Greater intensity of DNA
laddering was observed at the higher concentration. The data showed similar intensity
differences between the two cell concentrations in both the camptothecin and
staurosporine experiments (Fig. 1b & 1c). Both camptothecin concentrations (6 and 12
mM) induced DNA laddering at 24 hours post-induction (Fig. 1b). To prevent
concentration-induced necrosis, the lower camptothecin concentration (6 mM) was
deemed sufficient for future experiments.

Cell cycle using flow cytometry
Accumulation of cells at various stages of the cell cycle was observed following
the three treatments. Control HT2 cells maintained in interleukin 2 (IL-2) followed
standard distribution pattern in all experiments (Fig. 2, 3, & 4 controls). IL-2 deprivation
treatments characterized accumulation of cells in the G1 phase of the cell cycle (G1 DNA
content) following 12 hours of withdrawal. Late stage apoptosis was observed in these
cells after 24 hours, as depicted by the accumulation of cells with sub-G1 DNA content.
Massive cell death followed at 36 hours of deprivation (Fig. 2). Cell behavior following
camptothecin exposure was characterized by initial accumulation in the G1 phase of the
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cell cycle at 3 hours post-induction that lead to later arrest in S-phase at 6 hours (Fig. 3).
Apoptosis ensued at 12 hours as depicted by the accumulation of cells with sub-G1 DNA
content, and all cells were dead at 24 hours. Staurosporine treatment caused cell
accumulation in S- and G2/M-stage at 3 hours post-induction, later shifting to the G2/Mphase after 6 hours of exposure (Fig. 4). Significant accumulation in G2/M was visible at
12 hours, and most cells were dead at 24 hours.

Annexin V staining is an early marker of apoptotic HT-2 T lymphocytes: a flow cytometry
analysis.
Early stage apoptosis marked by phosphatidylserine (PS) externalization and
annexin V was observed with all three apoptosis inducers. In IL-2 deprived cells, annexin
V staining was observed prior to cell membrane permeabilization (determined by staining
with the fluorescent DNA binding dye 7-aminoactinomycin D or 7-AAD) between 12
and 24 hours of incubation (Fig. 5). In contrast, PS externalization was observed at 3
hours following camptothecin exposure (Fig. 6). The majority of the HT-2 cells were
found to enter late stages of apoptosis by 12 hours. Staurosporine treatment consistently
induced PS externalization between 6 and 12 hours post-induction, and entered late-stage
apoptosis by 24 hours (Fig. 7).

P27Kip1 protein levels are up-regulated in apoptotic HT-2 cells following induction with
IL-2 deprivation and camptothecin.
Alpha-tubulin steady state protein levels were used as a housekeeping control.
High levels of tubulin expression were observed across all time points and inducers (Fig.
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8a, b, c). These experiments confirmed proper quantification (20 micrograms per lane)
and loading of protein lysates on SDS-PAGE. P27Kip1 steady state, protein levels
increased within 12 hours of IL-2 withdrawal (Fig. 8d), and after 6 hours of camptothecin
exposure relative to control samples (Fig. 8e). No significant changes in Kip1 expression
were observed following staurosporine treatment, except at 24 hours, in which protein
levels were downregulated (Fig. 8f).
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Discussion
This research intended to better understand the role of three specific inducers in
triggering apoptosis in normal, interleukin-2 dependent mouse HT-2 T-lymphocytes.
Each treatment drove the cells to the same apoptotic fate, yet each led them there through
very distinct pathways and different kinetics. The unique nature of each pathway is
evidenced by cell cycle distribution and timing of early apoptotic markers. Each inducer
provoked accumulation of cells in distinct phases of the cell cycle prior to the
externalization of phosphatidylserine on their membrane surface, and subsequent DNA
fragmentation and death. Further differences between the modes of apoptosis were
observed through P27Kip1 protein quantification. This critical G1/S phase checkpoint
inhibitor protein was found to be significantly up-regulated in two of the treatments, IL-2
deprivation and camptothecin exposure, but down-regulated in the third (staurosporine).
These data suggest that the type of inducer may also be fundamental to the role of P27Kip1
role in either promoting or protecting from apoptosis.

Effectiveness of the inhibitors
IL-2 deprivation, camptothecin exposure, and staurosporine treatment are well
known inducers of programmed cell death (Crispin et al., 2011; Zeng et al., 2012; Simenc
& Lipnik-Stangeli, 2012). The current research has confirmed that each treatment is
equally effective in triggering internucleosomal DNA fragmentation (DNA laddering) in
HT-2 mouse T - lymphocytes. Agarose gel electrophoresis revealed that DNA laddering
was visible at both camptothecin concentrations following 24 hours, and the lower of the
dosage was selected for subsequent experiments to avoid necrosis. High concentrations of

19

apoptosis inducers, such as camptothecin or staurosporine, used to treat some cancer cell
lines have been found to induce necrosis instead of apoptosis (Zare-Mirakabadi et al.,
2012; Simenc & Lipnik-Stangeli, 2012). Any differences noted in band intensity here
were likely due to inconsistent cell concentrations. These experiments were carried out
to ensure that apoptosis was indeed stimulated by the chosen treatments. In this study, we
did not carry out a time course to determine the earliest onset of DNA laddering, but it is
well documented that this feature is a late event in the apoptotic pathway (Elmore, 2007).

The pre-apoptotic response
Our findings indicate that disruption of the cell cycle of HT-2 mouse Tlymphocytes is a precursor to apoptotic cell death. The cell cycle is a highly regulated
process equipped with various checkpoints that assess the condition of the cell as it is
replicated. Essential regulatory molecules at these checkpoints function to identify
problems or errors in cell cycle progression. Depending on the severity of the defect, the
cell’s progression will either be stalled as repairs are performed or redirected to
programmed cell death pathways. The immediacy of the transition to cell death, such as
apoptosis, is debated. Some forms of apoptosis have found no effect on cell cycle
distribution, indicated by immediate transition of the damaged cell out of the cell cycle
and no accumulation in any particular phase (Ishii et al., 2004). Others have studied
apoptosis inducers that promote alterations in cell cycle distribution, as cells accumulate
at a checkpoint prior to their death (Mercier et al., 2013; Fan et al., 2014). The present
study did find an effect on cell cycle distribution from the three inducers used. Induction
of apoptosis resulting from IL-2 deprivation led to accumulation in the G1 phase of the
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cell cycle, whereas camptothecin or staurosporine induction resulted in S and G2/M
phase accumulation, respectively.
The accumulation of cells in a specific phase of the cell cycle is typically referred
to as “cell cycle arrest,” and this process has typically been analyzed by flow cytometry
(Tong et al., 2014). There are two principal and distinct forms of cellular arrest,
quiescence and senescence. Quiescence is a reversible form of cell cycle arrest usually
caused by the withdrawal of growth factors or nutrients (Blagosklonny, 2011). In
contrast, during senescence, the cell cycle becomes blocked by DNA damaging agents,
radiation, tumor suppressors or cyclin-dependent kinase (CDK) inhibitors. However, no
signals are sent to discontinue the growth-promoting pathways. This propagated growth
signal results in an accumulation of cells in a given phase as the growth signals
propagate. The treatments used in this study showed senescent behavior prior to entrance
into apoptosis and cell fragmentation.
Evidence that implied a senescence-type response existed prior to apoptosis was
first observed through cell cycle analysis, and later confirmed with annexin V staining.
IL-2 deprived cells began accumulating significantly following 12 hours of incubation in
IL-2-deprived media. At that time, minimal genomic DNA fragmentation was noted (i.e.:
absence of cells with sub-G1 DNA content), indicating that cells were not entering late
stage apoptosis as they were beginning to accumulate in G1. Detection for early stage
apoptosis also indicated no apoptotic activity until cells had been deprived of IL-2 for 24
hours. Cellular arrest following camptothecin exposure occurred after 6 hours,
overlapping slightly with apoptotic changes that began at 6 hours and more significantly,
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at 12 hours. Finally, staurosporine experimental cells accumulated after 6 hours in G2/M
phase prior to entering apoptosis at 12 hours.

Early apoptotic changes and P27Kip1 expression
P27Kip1 is a well-known inhibitor of the cyclin dependent kinase complex cdk2cyclin A/E, and it plays an important role in regulating G1/S cell cycle arrest (Levkau et
al., 1998). In the current study, P27Kip1 protein steady state levels increased within 12
hours following IL-2 deprivation. This increase in inhibitor concentration occurred
simultaneously with phosphatidylserine externalization (annexin staining) in the induced
HT-2 cells. Previous studies have shown that IL-2 withdrawal in T-lymphocytes results
in G1 cell cycle arrest and upregulation of the P27Kip1 inhibitor (Huleatt et al., 2003).
More so, Huleatt et al. found highest P27Kip1 levels were associated with activated (rather
than deactivated) T-cells undergoing apoptosis resulting from cytokine withdrawal. These
data are consistent with the behaviors of the mouse HT-2 cells. Their time course for
induction however, does not coincide with that determined by the current study, as they
report accumulation as early as 4 hours, and increased P27Kip1 steady state levels after 6
hours of incubation. Interestingly, they found restricting P27Kip1 levels by using gene
deficient T-cells made the cells more susceptible to apoptosis, but inhibited their ability
to arrest prior to death. The data suggest a very close link between P27Kip1’s role in
proliferation and apoptosis in these cells. While its up-regulation appears to directly
induce apoptosis, cytokine deprivation may not require P27Kip1 to induce apoptosis, but
rather activates a phosphorylation-dependent death program (Janicke et al., 1996).
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The camptothecin experiment also showed that phosphatidylserine externalization
correlated temporally with increased P27Kip1 protein steady state levels after 6 hours of
exposure. The evidence provided by the IL-2 deprivation and camptothecin experiments
suggests that P27Kip1 is an integral initiator of the apoptotic response in mouse HT-2
cells. Both inducers inhibit mechanisms in early stages of the cell cycle, providing a
reasonable explanation for the up-regulation of P27Kip1 at the G1/S phase checkpoint. A
build up of cells in G1 resulting from cytokine withdrawal would promote P27Kip1
activity to move cells out of the cycle by initiating apoptosis. Accumulation in S phase
could slow the progression of cells from G1 to S, contributing to the hyperactivity of the
apoptotic inhibitor. The third inducer, however, initiated a contrary response in P27Kip1
regulation, as steady state levels decreased at 24 hours post-induction. Because
staurosporine induced cell cycle arrest in G2/M phase prior to fragmentation, it blocked
cells from dividing and reentering the initial growth phase. Cells beginning in S or G2/M
phase for IL-2 deprivation and G2/M phase for camptothecin experiments could divide
and reenter G1, increasing demand for P27Kip1 activity and stimulating inhibitor
production. In future experiments, we propose to quantify P27Kip1 via chemiluminescence
detection, to determine steady-state levels in IL-2 deprived cells, in which all cells reach
the G1/S checkpoint prior to apoptosis. High levels of P27Kip1 will also likely be observed
in camptothecin exposed cells, where all cells except those beginning the treatment in Sphase will pass through this checkpoint. Finally, staurosporine-treated cells will likely
have diminished P27Kip1 levels, as only those cells beginning in G1 will pass the
checkpoint.
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Future Work
This study aimed to better understand the mechanisms that control programmed
cell death in T-lymphocytes. We have identified appropriate cell and inducer
concentrations to initiate apoptosis in this growth factor-dependent cell line. Early and
late stage morphological changes have been identified in a time course fashion, and
evidence presented in this study suggests that the mode of induction dictates cell cycle
distribution and arrest prior to apoptosis. This body of work will serve as the primary
foundation as we continue to investigate apoptosis regulation in HT2 cells.
In addition to carrying out chemiluminescence detection in future work, we also
plan to improve documentation of the time course associated with programmed cell death
by quantifying late-stage apoptosis by flow cytometry using TUNEL assays. Finally,
using siRNA-or morpholino-mediated gene silencing, we hope to functionally
characterize the role of P27Kip1 during apoptosis in HT-2 cells. By inhibiting the
production of RNA transcripts and/or protein synthesis, we aim to determine if P27Kip1
promotes or discourages apoptosis, and how the inducer influences this inhibitor’s
function.
As our research continues, we also plan to explore the reversibility of the
apoptotic response with these specific inducers. Previous unpublished studies have
evaluated the reversibility of apoptosis with IL-2 withdrawal, and found that T-cells were
able to re-enter the cell cycle, regain function and viability with the reintroduction of the
cytokine 24 hours after deprivation (Lauzon, unpublished observations). Extensive work
has been performed on cancer cells and their ability to regain function following transient
apoptosis (Tang et al., 2009). These studies have found that even late state-apoptotic
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cancer cells in several cell lines were able to recover, although some with permanent
genetic alterations (Tang et al., 2012). We hope to investigate whether apoptosis induced
in HT-2 T-lymphocytes with camptothecin or staurosporine is also reversible, and if so,
what is the time course of reversibility. Furthermore, we would like to address if the
reversibility of apoptosis-mediated cell cycle arrest is phase-dependent.. Reversibility of
apoptosis may contribute to our understanding of failed cancer treatments or recurrent
cancers.
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Figure 1. Electrophoresis gel DNA fragmentation after 24-hour incubation. The gels
were used to determine optimal cell and/or toxin concentrations for each apoptosis
inducer. A) IL-2 deprivation experiment, lanes 1-5 (from left to right): MW markers, IL2(+) 100,000 cells/mL, IL-2(+) 200,000 cells/mL, IL-2(-) 100,000 cells/mL, IL-2(-)
200,000 cells/mL. B) Camptothecin (6mM) experiment, lanes 1-5 (from left to right):
MW markers, Campto(-) 100,000 cells/mL, Campto(-) 200,000 cells/mL, Campto(+)
100,000 cells/mL, Campto(+) 200,000 cells/mL C) Staurosporine (1uM) experiment,
lanes 1-5 (from left to right): MW markers, Stauro(-) 100,000 cells/mL, Stauro(-)
200,000 cells/mL, Stauro(+) 100,000 cells/mL, Stauro(+) 200,000 cells/mL. The optimal
cell concentration for all experiments was found to be 200,000 cells/mL. A camptothecin
concentration of 6 mM was sufficient to demonstrate apoptotic DNA laddering, while
staurosporine induced laddering at a concentration of 1uM.
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Figure 2. Flow cytometry cell cycle analysis following a 36-hour time course IL-2
deprivation treatment. HT-2 cells were incubated with 7-aminoactinomycin D (7AAD) to determine changes in cell cycle distribution following apoptosis induction
following IL-2 deprivation. Control HT-2 cells grown in IL-2 (+) media demonstrate
typical cell cycle distribution patterning with brown representing sub-G1 DNA content,
pink representing cells with G1 DNA content, green representing cells in S phase, and
blue representing cells in G2/Mitosis. Cells begin to accumulate in G1 at 12 hours
following IL-2 deprivation, and subsequently begin to fragment (sub-G1 peak) at 24
hours. By 36 hours, the majority of cells have died. Percent values for each phase of the
cell cycle (DNA content) are indicated in each histogram.
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Figure 3. Flow cytometry cell cycle analysis following a 24-hour time course with 6
mM camptothecin treatment. HT-2 cells were incubated with 7-aminoactinomycin D
(7-AAD) to determine changes in cell cycle distribution following apoptosis induction
with camptothecin. Control cells grown in IL-2 (+) media demonstrate typical cell cycle
distribution patterning with brown representing sub-G1 DNA content, pink representing
cells with G1 DNA content, green representing cells in S phase, and blue representing
cells in G2/Mitosis. Initial accumulation of cells in G1-phase occurs at 3 hours following
camptothecin exposure and the majority of cells accumulate in S-phase by 6 hours of
incubation. Notable death is observed after 12 hours of exposure (sub-G1 DNA peak) and
nearly all cells have died at 24 hours.
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Figure 4. Flow cytometry cell cycle analysis following a 24-hour time course with 1
uM staurosporine treatment. HT-2 cells were incubated with 7-aminoactinomycin D
(7-AAD) to determine changes in cell cycle distribution following apoptosis induction
with staurosporine. Control cells grown in IL-2 (+) media demonstrate a typical cell cycle
distribution pattern with brown representing cells with sub-G1 DNA content, pink
representing cells with G1 DNA content, green representing cells in S phase, and blue
representing cells in G2/Mitosis. Accumulation of cells in S and G2/M phases of the cell
cycle occurs 3 hours following staurosporine exposure. This accumulation shifts toward
the G2/M phase after 6 hours, and most cells have accumulated in G2/M phase by 12
hours. By 24 hours, the majority of cells have died.
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Figure 5. Flow cytometry analysis of Annexin V staining following a 24 hour IL-2
deprivation time course. Since phosphatidylserine externalization is an early event
during apoptosis, Annexin V staining was used to identify the time required to initiate
apoptosis following deprivation. Healthy, non-apoptotic cells are shown in the lower lefthand quadrant (7-AAD and Annexin V-PE negative). Early stage apoptosis marked by
phosphatidylserine externalization and Annexin V binding is observed in the lower righthand quadrant (7-AAD negative, annexin V positive). Late stage apoptosis marked by
plasma membrane degradation and 7-AAD staining is observed in the upper right-hand
quadrant (7-AAD and annexin V positive). Early stages of apoptosis in IL-2 deprived
cells are observed to occur between 12 and 24 hours following IL-2 deprivation.
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Figure 6. Flow cytometry analysis of Annexin V staining following a 24-hour time
course with 6 mM camptothecin. Since phosphatidylserine externalization is an early
event during apoptosis, Annexin V staining was used to identify the time required to
initiate apoptosis following induction with camptothecin. Healthy, non-apoptotic cells
are shown in the lower left-hand quadrant (7-AAD and Annexin V-PE negative). Early
stage apoptosis marked by phosphatidylserine externalization and Annexin binding is
observed in the lower right-hand quadrant (7-AAD negative, annexin V positive). Late
stage apoptosis marked by plasma membrane degradation and 7-AAD staining is
observed in the upper right-hand quadrant (7-AAD and annexin V positive). Significant
induction of apoptosis commences after 3 hours of incubation, and the majority of cells
enter late stages of apoptosis by 12 hours.
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Figure 7. Flow cytometry analysis of Annexin V staining following a 24-hour time
course with 1 uM staurosporine. Since phosphatidylserine externalization is an early
event during apoptosis, Annexin V staining was used to identify the time required to
initiate apoptosis following induction with camptothecin. Healthy, non-apoptotic cells are
shown in the lower left-hand quadrant (7-AAD and Annexin V-PE negative). Early stage
apoptosis marked by phosphatidylserine externalization and Annexin V binding is
observed in the lower right-hand quadrant (7-AAD negative, annexin V positive). Late
stage apoptosis marked by plasma membrane degradation and 7-AAD staining is
observed in the upper right-hand quadrant (7-AAD and annexin V positive). Early
apoptosis is observed between 6 and 12 hours of incubation and the majority of cells have
entered late-stage apoptosis by 24 hours.
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Figure 8. SDS-PAGE and immunoblotting with anti-tubulin and P27Kip1 specific
antibodies. Alpha-tubulin was used as a housekeeping control. A) IL-2 deprivation with
anti-tubulin staining: lanes 1-3 (from left to right) depict 12hr IL-2(-), 24hr IL-2(-), 24hr
IL-2(+). B) 6 mM camptothecin with anti-tubulin staining: lanes 1-5 (from left to right)
depict 3hr Campto(+), 6hr Campto(+), 12hr Campto(+), 24hr Campto(+), 24hr Campto(). C) 1 µM staurosporine with anti-tubulin staining: lanes 1-5 (from left to right) depict
3hr Stauro(+), 6hr Stauro(+), 12hr Stauro(+), 24hr Stauro(+), 24hr Stauro(-). D) IL-2
deprivation with anti-P27Kip1 staining: lanes 1-3 (from left to right) depict 12hr IL-2(-),
24hr IL-2(-), 24hr IL-2(+). E) 6 mM Camptothecin with anti-P27Kip1 staining: lanes 1-5
(from left to right) depict 3hr Campto(+), 6hr Campto(+), 12hr Campto(+), 24hr
Campto(+), 24hr Campto(-). F) 1 µM staurosporine with anti-P27Kip1 staining: lanes 1-5
(from left to right) depict 3hr Stauro(+), 6hr Stauro(+), 12hr Stauro(+), 24hr Stauro(+),
24hr Stauro(-). P27Kip1 protein steady state levels increase within 12 and 6 hours
following IL-2 and camptothecin treatments, respectively.
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